Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia
Top Cited Papers
- 1 July 2006
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (1) , 40-49
- https://doi.org/10.1016/j.ajog.2005.07.049
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- Pre-eclampsiaThe Lancet, 2005
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsiaPublished by Wolters Kluwer Health ,2003
- Pre-eclampsia, antiretroviral therapy, and immune reconstitutionThe Lancet, 2002
- Is preeclampsia an infectious disease?Acta Obstetricia et Gynecologica Scandinavica, 2001
- Is infection a major risk factor for preeclampsia?Medical Hypotheses, 2001
- Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcusPublished by Wolters Kluwer Health ,1998
- Urogenital infection in preeclampsiaInternational Journal of Gynecology & Obstetrics, 1995
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995
- Which plasma factors bring about disturbance of endothelial function in pre-eclampsia?The Lancet, 1994